SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-011131
Filing Date
2018-08-14
Accepted
2018-08-14 17:12:35
Documents
46
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cpix-20180630.htm   iXBRL 10-Q 933446
2 PINNACLE AMENDMENT q22018-exhibit101.htm EX-10.1 24114
3 q22018-exhibit311.htm EX-31.1 15004
4 q22018-exhibit312.htm EX-31.2 17608
5 q22018-exhibit321.htm EX-32.1 11281
  Complete submission text file 0001628280-18-011131.txt   3315068

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cpix-20180630.xsd EX-101.SCH 19723
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cpix-20180630_cal.xml EX-101.CAL 51590
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cpix-20180630_def.xml EX-101.DEF 67595
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cpix-20180630_lab.xml EX-101.LAB 252100
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cpix-20180630_pre.xml EX-101.PRE 154994
11 EXTRACTED XBRL INSTANCE DOCUMENT cpix-20180630_htm.xml XML 516149
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 181018818
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1